Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C

Direct-acting antivirals (DAA) are highly effective for the treatment of hepatitis C (HCV), although there are limited data on the safety and efficacy of DAA therapy in hepatitis C-positive individuals awaiting liver transplantation for hepatocellular carcinoma (HCC). METHODS: We conducted a retrosp...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Transplant Direct
Huvudupphovsmän: Tse, Chung Sang, Yang, Ju Dong, Mousa, Omar Y., Nelson, Kevin M., Pungpapong, Surakit, Keaveny, Andrew, Aqel, Bashar A., Vargas, Hugo, Dickson, Rolland C., Watt, Kymberly, Gores, Gregory J., Roberts, Lewis R., Leise, Michael D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2020
Ämnen:
Liver Transplantation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725260/
https://ncbi.nlm.nih.gov/pubmed/33324740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001049
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk